OmniAb, Inc.
corporate_fare Company Profile
OmniAb, Inc. (NASDAQ:OABI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 10 items for OABI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-30, rated 7/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for OABI spans 8-K, 10-Q, 10-K.
Recent high-impact activity:
- OmniAb Q3 Revenue $4.0M, Raises 2026 Revenue Guidance to $35-39M
- OmniAb Lifts 2026 Revenue and Cash Guidance After Q3 Revenue Nearly Doubles
- OmniAb Inks Global Ion Channel Deal With Eli Lilly Worth Up to $370M in Milestones
- OmniAb Q2 Revenue Triples Estimates, Full-Year Outlook Raised
- OmniAb Q2 Revenue Surges 244% to $13.4M, Raises Full-Year Outlook on Partner Momentum
Financial Snapshot
Short Interest & Short Volume
5.21 days to coverFINRA reported short interest of 8,003,396 shares in OABI as of the October 30, 2026 settlement, a 6.3% decrease from the prior period — about 5.2 days to cover at its recent average daily volume. On November 20, 2026, 32.3% of OABI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.